, Population par sexe et groupe d'âges en 2019 | Insee

D. Sur,

, Projections de population à l'horizon 2060 -Insee Première -1320

, Les dépenses de santé en 2017 édition 2018 DRE.pdf [Internet

F. Ventes-de-médicaments-en, le rapport d'analyse de l'année 2013 -Communiqué -ANSM : Agence nationale de sécurité du médicament et des produits de santé

P. S. Legrain, Consommation Médicamenteuse chez le Sujet Agé, 2005.

T. S. Field, J. H. Gurwitz, L. R. Harrold, J. Rothschild, K. R. Debellis et al., Risk factors for adverse drug events among older adults in the ambulatory setting, J Am Geriatr Soc. août, vol.52, issue.8, pp.1349-54, 2004.

J. Jyrkkä, H. Enlund, M. J. Korhonen, R. Sulkava, and S. Hartikainen, Polypharmacy status as an indicator of mortality in an elderly population, Drugs Aging, vol.26, issue.12, pp.1039-1087, 2009.

, A Systematic Review of the Impact of Potentially Inappropriate Medication on Health Care Utilization and Costs Among Older Adults. -PubMed -NCBI

D. Sur,

A. Trinh-duc, J. Doucet, B. Bannwarth, B. Trombert-paviot, F. Carpentier et al., Admissions des sujets âgés aux Services d'Accueil des Urgences pour effets indésirables médicamenteux, Thérapie. 1 sept, vol.62, issue.5, pp.437-478, 2007.

L. Kanagaratnam, A. Taam, M. Heng, M. , D. Boissieu et al.,

, Therapie, vol.70, issue.5, pp.477-84, 2015.

V. Sehgal, S. Bajwa, R. Sehgal, A. Bajaj, U. Khaira et al., Polypharmacy and potentially inappropriate medication use as the precipitating factor in readmissions to the hospital, J Fam Med Prim Care. avr, vol.2, issue.2, pp.194-203, 2013.

, Prevalence of potentially inappropriate prescribing in older people in primary care and its association with hospital admission: longitudinal study | The BMJ

D. Sur,

C. Cahir, K. Bennett, C. Teljeur, and T. Fahey, Potentially inappropriate prescribing and adverse health outcomes in community dwelling older patients, Br J Clin Pharmacol. janv, vol.77, issue.1, pp.201-211, 2014.

, Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults, American Geriatrics Society, vol.67, issue.4, pp.674-94, 2019.

M. Laroche, J. Charmes, and M. L. , Potentially inappropriate medications in the elderly: a French consensus panel list, Eur J Clin Pharmacol. août, vol.63, issue.8, pp.725-756, 2007.

P. O. Lang, M. Dramé, B. Guignard, R. Mahmoudi, I. Payot et al., Les critères STOPP/START.v2 : adaptation en langue française, NPG Neurol -Psychiatr -Gériatrie. 1 déc, vol.15, issue.90, pp.323-359, 2015.

A. Frey-geoffret and . Critères, START version 2: étude de faisabilité de l'utilisation d'une version informatisée en médecine générale, 2016.

F. Moriarty, K. Bennett, T. Fahey, R. A. Kenny, and C. Cahir, Longitudinal prevalence of potentially inappropriate medicines and potential prescribing omissions in a cohort of community-dwelling older people, Eur J Clin Pharmacol. avr, vol.71, issue.4, pp.473-82, 2015.

P. Gallagher, P. O. Lang, A. Cherubini, E. Topinková, A. Cruz-jentoft et al., Prevalence of potentially inappropriate prescribing in an acutely ill population of older patients admitted to six European hospitals, Eur J Clin Pharmacol, vol.67, issue.11, pp.1175-88, 2011.

, Caraveo -Prescriptions hors AMM des inhibiteurs de la pompe, Etat des lieux de la consommation des benzodiazépines -Point d'Information -ANSM : Agence nationale de sécurité du médicament et des produits de santé

, Avout -Prescription d'une statine en prévention primaire

E. Boisdin, Abstract : Background : Elderly people with frailty factors are concerned by polypharmacy. They are involved in iatrogenic disease which has become increasingly important as the aged population grows. STOPP and START (Screening Tool to Alert Doctors to Right Treatement) is a tool whose purpose is to optimize elderly people's prescriptions. Goals°: The study's main goal was to assess improvement of iatrogenic médication's prevention for elderly people in primary care. General practitioners's precription was evaluate before and after an education to the tool STOPP and START. The second goal was to underline ltool's limits daily practice for general practitioners. Method : For this pre-post study, general practitioners from Albanais's area in the county of Haute-Savoie participated in a medical training on iatrogenesis's prevention which included presentation of STOPP and START tool. Drug prescriptions from people over 65 with polyphamacy have been collected before and after training. A survey was adressed to general practitioners asking about their profil and tool's assessment. Results : The amount of drugs prescription didn't change significantly after training, Etude prospective sur les déterminants de la déprescription des médicaments en médecine générale, 2011.

, Conclusion : The training about iatrogenesis's prevention supported by a tool for optimizing prescriptions of the elderly people is not enough, -depth work on obstacles to deprescribing appears necessary. KEY WORDS : Iatrogenic diseases, geriatrics, elderly